IDENTIFIED BY NGS, PCR OR IHC

Clinical trials for IDENTIFIED BY NGS, PCR OR IHC explained in plain language.

Never miss a new study

Get alerted when new IDENTIFIED BY NGS, PCR OR IHC trials appear

Sign up with your email to follow new studies for IDENTIFIED BY NGS, PCR OR IHC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Blood test guides cancer treatment to stop recurrence

Disease control Ongoing

This small, early-stage study is testing whether the drug pembrolizumab can prevent cancer from returning in people who have had surgery to remove a solid tumor but still have traces of tumor DNA in their blood. The trial involves about 17 participants who will receive the drug f…

Matched conditions: IDENTIFIED BY NGS, PCR OR IHC

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

IDENTIFIED BY NGS, PCR OR IHC

Get alerted when new IDENTIFIED BY NGS, PCR OR IHC trials appear

Blood test guides cancer treatment to stop recurrence